Marketing-authorisation holder · Canada
Pharmascience Inc
1,373 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
1,373 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 1,373
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETAMINOPHEN EXTRA STRENGTH500 mg · Tablet | Paracetamol | Canada | Authorised | |
| ACID CONTROLLER MAXIMUM STRENGTH20 mg · Tablet | Famotidine | Canada | Authorised | |
| ALLERGY CONTROL DESLORATADINE5 mg · Tablet | Desloratadine | Canada | Authorised | |
| ALLERGY FORMULA25 mg · Tablet | Diphenhydramine | Canada | Authorised | |
| ANALGESIC AND MUSCLE RELAXANT400 mg + 500 mg · Tablet | Ibuprofen, Methocarbamol | Canada | Not marketed | 2012 |
| ANTI-NAUSEANT50 mg · Tablet | Dimenhydrinate | Canada | Authorised | |
| ARTHRITIS PAIN RELIEF650 mg · Tablet (Extended-Release) | Paracetamol | Canada | Not marketed | 2022 |
| ASA81 mg · Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Marketed | 2015 |
| ASA 81 MG81 mg · Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Marketed | 2001 |
| ASA DAILY LOW DOSE81 mg · Tablet (Chewable) | Acetylsalicylic acid | Canada | Marketed | 2013 |
| ASAPHEN80 mg · Tablet (Chewable) | Acetylsalicylic acid | Canada | Marketed | 1995 |
| ASAPHEN E.C. 80 MG80 mg · Tablet (Delayed-Release) | Acetylsalicylic acid | Canada | Marketed | 1998 |
| ASAPHEN PLUS 325325 mg · Tablet | Acetylsalicylic acid | Canada | Authorised | |
| BENZOYL PEROXIDE LOTION5 % · Lotion | Benzoyl peroxide | Canada | Authorised | |
| CLARILAX1 g / g · Powder For Solution | Macrogol | Canada | Authorised | |
| COLACE10 mg / ml · Solution | Docusate | Canada | Marketed | 1996 |
| COLACE CAPSULES100 mg · Capsule | Docusate | Canada | Marketed | 1997 |
| COLACE CLEAR100 mg · Capsule | Docusate | Canada | Marketed | 2019 |
| COLACE PLUS STIMULANT LAXATIVE50 mg + 8.6 mg · Tablet | Docusate, Senna | Canada | Marketed | 2021 |
| COLACE SYRUP20 mg / 5 ml · Syrup | Docusate | Canada | Marketed | 1997 |
| CYTOSAR100 mg / ml · Solution | Cytarabine | Canada | Authorised | |
| CYTOSAR20 mg / ml · Solution | Cytarabine | Canada | Authorised | |
| DEQUADIN0.25 mg · Lozenge | Dequalinium | Canada | Marketed | 1996 |
| DEQUADIN ORAL PAINT0.5 % / w/v · Solution | Dequalinium | Canada | Not marketed | 1995 |
| DEQUADIN ORAL SPRAY0.5 % / w/v · Solution | Dequalinium | Canada | Not marketed | 2022 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 1,373 | 674 | 699 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.